Evidence map›Paper›PMID 38482620›Full record

ArticleCurrent drug discovery technologies2024

Synthesis, Molecular Docking, and Biological Evaluation of Novel Indole-triazole Conjugates.

Paras Berwal, Suman Rohilla, Nancy Mathur, Ketki Rani

Abstract read
PubMed Publisher
In one paragraph

Article in Current drug discovery technologies, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Paras BerwalDepartment of Pharmaceutical Chemistry, SGT College of Pharmacy, SGT University, Gurugram, Haryana, India.
Suman RohillaDepartment of Pharmaceutical Chemistry, SGT College of Pharmacy, SGT University, Gurugram, Haryana, India.ORCID 0000-0002-2040-4112
Nancy MathurDepartment of Pharmaceutical Chemistry, SGT College of Pharmacy, SGT University, Gurugram, Haryana, India.
Ketki RaniDepartment of Pharmaceutical Chemistry, SGT College of Pharmacy, SGT University, Gurugram, Haryana, India.
Shree Guru Gobind Singh Tricentenary University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIndole-triazole conjugates have emerged as promising candidates for new drug development. Their distinctive structural characteristics, coupled with a wide array of biological activities, render them a captivating and promising field of research for the creation of novel pharmaceutical agents.

objectiveThis study aimed to synthesize indole-triazole conjugates to investigate the influence of various substituents on the functional characteristics of indole-triazole hybrids. It also aimed to study the binding modes of new hybrids with the DNA Gyrase using molecular docking studies.

methodsA new set of indole-triazole hybrids was synthesized and characterized using various physicochemical and spectral analyses. All hybrids underwent

resultsPharmacokinetic predictions of synthesized hybrids indicated favourable pharmacokinetic profiles, and none of the compounds violated the Lipinski rule of five. Notably, compound 6, featuring a cyclohexanol substituent, demonstrated superior antimicrobial and antioxidant activity (EC

conclusionIn summary, our research underscores the efficacy of molecular hybridization in shaping the physicochemical, pharmacokinetic, and biological characteristics of novel indole-triazole derivatives.

Indexed as

Anti-Bacterial AgentsAntioxidantsDNA GyraseIndolesMolecular Docking SimulationTriazolesMicrobial Sensitivity TestsStructure-Activity RelationshipAnti-Bacterial AgentsAntioxidantsDNA GyraseIndolesTriazolesantibacterialantioxidant.Indolemolecular hybridstriazole

Identifiers

PMID38482620
OpenAlexW4392812471

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.